Risk factors for non-compliance with continuous positive airway pressure therapy in patients with obstructive sleep apnea and paroxysmal atrial fibrillation

Author(s):  
Gunn Marit Traaen ◽  
Maria Kristina Vik-Strandli ◽  
Britt Øverland ◽  
Lars Aakerøy ◽  
Tove-Elizabeth Hunt ◽  
...  
2014 ◽  
Vol 30 (6) ◽  
pp. 502-505 ◽  
Author(s):  
Vichai Senthong ◽  
Jarin Chindaprasirt ◽  
Pattarapong Makarawate ◽  
Panita Limpawattana ◽  
Akkaranee Timinkul ◽  
...  

2021 ◽  
Vol 22 (5) ◽  
pp. 2300
Author(s):  
Ronni Baran ◽  
Daniela Grimm ◽  
Manfred Infanger ◽  
Markus Wehland

Obstructive sleep apnea (OSA) is a common disease, with approximately 3–7% of men and 2–5% of women worldwide suffering from symptomatic OSA. If OSA is left untreated, hypoxia, microarousals and increased chemoreceptor stimulation can lead to complications like hypertension (HT). Continuous positive airway pressure (CPAP) is the most common treatment for OSA, and it works by generating airway patency, which will counteract the apnea or hypopnea. More than one billion people in the world suffer from HT, and the usual treatment is pharmacological with antihypertensive medication (AHM). The focus of this review will be to investigate whether the CPAP therapy for OSA affects HT.


2015 ◽  
Vol 116 (11) ◽  
pp. 1767-1773 ◽  
Author(s):  
Waqas T. Qureshi ◽  
Usama bin Nasir ◽  
Shehabaldin Alqalyoobi ◽  
Wesley T. O'Neal ◽  
Sagar Mawri ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document